BDNF and Parkinson disease: Moreover, the decrease in expression and immunoreactivity of BDNF was observed in PD mice (p < 0.001) (Fig. 7B; p < 0.001; Fig. 8B) respectively and there was prominent elevation in expression and immunoreactivity of BDNF in OLE treated group (p < 0.01).